Development of an allogeneic product by CAR-T cells TCR knock-down

被引：1
|
作者：
Raitano, Susanna [1 ]
Bornschein, Simon [1 ]
Bolsee, Jennifer [1 ]
Marijsse, Jerome [1 ]
Marchand, Celine [1 ]
Huberty, Fanny [1 ]
Violle, Benjamin [1 ]
N'Guyen, Thuy [1 ]
Jacques-Hespel, Celine [1 ]
Ramelot, Nancy [1 ]
Houssa, Julien [1 ]
Agaugue, Sophie [1 ]
Gilham, David Edward [1 ]
机构：
[1] Celyad SA, Mt Saint Guibert, Belgium
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e15040
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15040
引用
收藏
页数：1
相关论文
共 50 条
  • [41] LMNA Knock-Down Affects Differentiation and Progression of Human Neuroblastoma Cells
    Maresca, Giovanna
    Natoli, Manuela
    Nardella, Marta
    Arisi, Ivan
    Trisciuoglio, Daniela
    Desideri, Marianna
    Brandi, Rossella
    D'Aguanno, Simona
    Nicotra, Maria Rita
    D'Onofrio, Mara
    Urbani, Andrea
    Natali, Pier Giorgio
    Del Bufalo, Donatella
    Felsani, Armando
    D'Agnano, Igea
    PLOS ONE, 2012, 7 (09):
  • [42] Retroviral vector for knock-down of gene expression in mammalian cells.
    Sugao, K
    Shirane, D
    Hirose, K
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2003, 91 : 291P - 291P
  • [43] KINETICS OF EXPANSION AND PHENOTYPE OF UCART19 CELLS IN THE FIRST CLINICAL TRIAL OF A UNIVERSAL ALLOGENEIC CAR-T CELL PRODUCT
    Jozwik, A.
    Graham, C.
    Dunlop, A.
    Sanchez, K.
    Yallop, D.
    Patten, P.
    Pagliuca, A.
    Mufti, G.
    Gauthier, L.
    Zinai, A.
    Dupouy, S.
    Balandraud, S.
    Poirot, C.
    Philippe, A.
    Simon, F.
    Konto, C.
    Ganguly, B.
    Pertel, T.
    Sasu, B.
    Benjamin, R.
    HUMAN GENE THERAPY, 2018, 29 (11) : A17 - A17
  • [44] Physiological (TCR-like) regulated lentiviral vectors for the generation of improved CAR-T cells
    Tristan-Manzano, M.
    Maldonado-Perez, N.
    Justicia-Lirio, P. L.
    Munoz, P.
    Cortijo-Gutierrez, M.
    Pavlovic, K.
    Jimenez-Moreno, R.
    Nogueras, S.
    Carmona, M. D.
    Sanchez-Hernandez, S.
    Aguilar-Gonzalez, A.
    Castella, M.
    Juan, M.
    Marchal, J. A.
    Maranon, C.
    Benabdellah, K.
    Herrera, C.
    Martin, F.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A8 - A8
  • [45] Preclinical Development of CTX120, an Allogeneic CAR-T Cell Targeting Bcma
    Dar, Henia
    Henderson, Daniel
    Padalia, Zinkal
    Porras, Ashley
    Mu, Dakai
    Kyungah, Maeng
    Police, Seshidhar
    Kalaitzidis, Demetrios
    Terrett, Jonathan
    Sagert, Jason
    BLOOD, 2018, 132
  • [46] Allogeneic anti-PTK7 CAR-T cells for the treatment of solid tumors
    Levitsky, Katie
    Li, Zejun
    Minh Thu Pham
    Maeng, Kelly
    Hanley, Luke
    Sagert, Jason
    Terrett, Jon
    Dutta-Simmons, Jui
    Allen, Melanie
    CANCER RESEARCH, 2020, 80 (16)
  • [47] CAR-T cells for cancer immunotherapy
    Xie, Yangyang
    Li, Xiaotong
    Wu, Jingyi
    Zeng, Huiling
    Boucetta, Hamza
    Wang, Binru
    Yang, Pei
    He, Wei
    CHINESE CHEMICAL LETTERS, 2023, 34 (09)
  • [48] Clinical pharmacology of CAR-T cells
    Bondanza, A.
    HUMAN GENE THERAPY, 2016, 27 (11) : A6 - A6
  • [49] CAR-T cells for solid tumors
    不详
    NATURE BIOTECHNOLOGY, 2023, 41 (05) : 588 - 588
  • [50] CAR-T cells for cancer immunotherapy
    Yangyang Xie
    Xiaotong Li
    Jingyi Wu
    Huiling Zeng
    Hamza Boucetta
    Binru Wang
    Pei Yang
    Wei He
    ChineseChemicalLetters, 2023, 34 (09) : 73 - 82
12345